Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T,t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adducts

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 9, 2007, Pages 3378-3385

  Kaur, Siminder ^a   Greaves, Peter ^a   Cooke, Darren N ^a   Edwards, Richard ^b   Steward, William P ^a   Gescher, Andreas J ^a   Marczylo, Timothy H ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Breast cancer; Catechins; Chemoprevention; Malondialdehyde; Theaflavins

Indexed keywords

BIFLAVONOID; CASPASE 3; CATECHIN; THEAFLAVIN; VIRUS T ANTIGEN;

ANIMAL; APOPTOSIS; ARTICLE; CHEMISTRY; DNA ADDUCT; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; MOUSE; TEA; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; BIFLAVONOIDS; CASPASE 3; CATECHIN; CELL LINE, TUMOR; DNA ADDUCTS; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; TEA;

CAMELLIA SINENSIS; MUS; MUS MUSCULUS; RODENTIA; SIMIAN VIRUS 40;

EID: 34249308188     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf0633342     Document Type: Article

References (43)

1. Parkin, D.; Muir, C.; Whelan, S.; Gao, Y.-T.; Ferlay, J.; Powell, J. Cancer incidence in five continents. In IARC Scientific Publications; IARC Press: Lyon, 1992; Vol. 6, number 120.
2. Ernster, V. L.; Barclay, J.; Kerlikowske, K.; Grady, D.; Henderson, C. Incidence of and treatment for ductal carcinoma in situ of the breast. J. Am. Med. Assoc. 1996, 275, 913-918.
3. Li, C. I.; Daling, J. R.; Malone, K. E. Age-specific incidence rates of in situ breast carcinomas by histological type, 1980 to 2001. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 1008-1011.
4. Colditz, G. A. Epidemiology and prevention of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 768-772.
5. Kolonel, L. Cancer patterns of four ethnic groups in Hawaii. JNCI 1980, 65, 1127-1139.
6. Ferlay, J.; Bray, F.; Pisani, P.; Parkin, D. M. Globocan 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base; IARC Press: Lyon, 2004; Vol. 5.
7. Ziegler, R. G.; Hoover, R. N.; Pike, M. C.; Hildesheim, A.; Nomura, A. M. Y.; West, D. W.; Wuwilliams, A. H.; Kolonel, L. N.; Hornross, P. L.; Rosenthal, J. F.; Hyer, M. B. Migration patterns and breast cancer risk in Asian-American women. JNCI 1993, 85, 1819-1827.
8. World Cancer Research Fund/American Institute for Cancer Research. Cancer, nutrition and food: Breast. In Food, Nutrition and the Prevention of Cancer: A Global Perspective; World Cancer Research Fund/American Institute for Cancer Research: Washington, DC, 1997; pp 252-287.
9. Wu, A. H.; Yu, M. C.; Tseng, C. C.; Hankin, J.; Pike, M. C. Green tea and risk of breast cancer in asian americans. Int. J. Cancer 2003, 106, 574-579.
10. Inoue, M.; Tajima, K.; Mizutani, M.; Iwata, H.; Iwase, T.; Miura, S.; Hirose, K.; Hamajima, N.; Tominaga, S. Regular consumption of green tea and the risk of breast cancer recurrence: Follow-up study from the Hospital-based epidemiologic research program at Aichi cancer center (HERPACC). Jpn. Cancer Lett. 2001, 167, 175-182.
11. Hou, Z.; Lambert, J. D.; Chin, K. V.; Yang, C. S. Effects of tea polyphenols on signal transduction pathways related to cancer prevention. Mutat. Res. 2004, 555, 3-19.
12. Crespy, V.; Williamson, G. A review of the health effects of green tea catechins in in vivo animal models. J. Nutr. 2004, 134, 3431S-3440S.
13. Kohlmeier, L.; Weterings, K. G. C.; Steck, S.; Kok, F. J. Tea and cancer prevention: An evaluation of the epidemiologic literature. Nutr. Cancer 1997, 27, 1-13.
14. Zhou, J. R.; Yu, L.; Mai, Z.; Blackburn, G. L. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int. J. Cancer 2004, 108, 8-14.
15. Rogers, A. E.; Hafer, L. J.; Iskander, Y. S.; Yang, C. S. Black tea and mammary gland carcinogenesis by 7, 12-dimethylbenz-[a]anthracene in rats fed control or high fat diets. Carcinogenesis 1998, 19, 1269-1273.
16. Weisburger, J. H.; Rivenson, A.; Garr, K.; Aliaga, C. Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett. 1997, 114, 323-327.
17. Yang, C. S.; Maliakal, S.; Meng, X. Inhibition of carcinogenesis by tea. Ann. Rev. Pharmacol. Toxicol. 2002, 42, 25-54.
18. Liang, Y. C.; Chen, Y. C.; Lin, Y. L.; Shiau, S. Y. L.; Ho, C. T.; Lin, J. K. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3, 3′-digallate. Carcinogenesis 1999, 20, 733-736.
19. Leung, L. K.; Su, Y.; Chen, R.; Zhang, Z.; Huang, Y.; Chen, Z. Y. Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J. Nutr. 2001, 131, 2248-2251.
20. Mulder, T. P. J.; van Platerink, C. J.; Wejnand Schuyl, P. J.; van Amelsvoort, J. M. M. Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B: Biomed. Sci. Appl. 2001, 760, 271-279.
21. Maroulakou, I. G.; Anver, M.; Garrett, L.; Green, J. E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. PNAS 1994, 91, 11236-11240.
22. Mietz, J. A.; Unger, T.; Huibregtse, J. M.; Howley, P. M. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 1992, 11, 5013-5020.
23. Dyson, N.; Buchkovich, K.; Whyte, P.; Harlow, E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 1989, 58, 249-255.
24. Yoshidome, K.; Shibata, M. A.; Couldrey, C.; Korach, K. S.; Green, J. E. Estrogen promotes increased mammary tumor development in C3(1)/SV40 large T antigen transgenic mice: paradoxical loss of estrogen receptor alpha expression during tumor progression. Cancer Res. 2000, 60, 6901-6910.
25. Green, J. E.; Shibata, M. A.; Yoshidome, K.; Liu, M. L.; Jorcyk, C.; Anver, M. R.; Wigginton, J.; Wiltrout, R.; Shibata, E.; Kaczmarczyk, S.; Wang, W.; Liu, Z. Y.; Calvo, A.; Couldrey, C. The C3(1)/SV40 T antigen transgenic mouse model of mammary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 2000, 19, 1020-1027.
26. Chen, C. W.; Ho, C. T. Antioxidant properties of polyphenols extracted from green and black teas. J. Food Lipids 1995, 2, 35-46.
27. Pryor, W. A. Cancer and free radicals. In Antimutagenesis and Anticarcinogenesis Mechanisms; Shankel, D. M., Hartman, P. E., Kada, T., Hollaender, A., Eds.; Plenum Press: New York, 1986; pp 45-59.
28. Bartsch, H.; Nair, J. Oxidative stress and lipid peroxidation-derived DNA lesions in inflammation driven carcinogenesis. Cancer Detect. Prev. 2004, 28, 385-391.
29. Wang, M.; Dhingra, K.; Hittelman, W. N.; Liehr, J. G.; de Andrade, M.; Li, D. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol. Biomarkers Prev. 1996, 5, 705-710.
30. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3, 768-780.
31. Budihardjo, I.; Oliver, H.; Lutter, M.; Luo, X.; Wang, X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 1999, 15, 269-290.
32. Workman, P.; Twentyman, P.; Balkwill, F.; Balmain, A.; Chaplin, D.; Double, J.; Embleton, J.; Newell, D.; Raymond, R.; Stables, J.; Stephens, T.; Wallace, J. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br. J. Cancer 1998, 77, 1-10.
33. Leuratti, C.; Singh, R.; Lagneau, C.; Farmer, P. B.; Plastaras, J. P.; Marnett, L. J.; Shuker, D. E. G. Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay. Carcinogenesis 1998, 19, 1919-1924.
34. Li, C.; Lee, M. J.; Sheng, S.; Meng, X. F.; Prabhu, S.; Winnik, B.; Huang, B. M.; Chung, J. Y.; Yan, S. Q.; Ho, C. T.; Yang, C. S. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion Chem. Res. Toxicol. 2000, 13, 177-184.
35. Liao, S.; Umekita, Y.; Guo, J.; Kokontis, J. M.; Hiipakka, R. A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 1995, 96, 239-243.
36. Sartippour, M. R.; Heber, D.; Ma, J.; Lu, Q.; Go, V. L.; Nguyen, M. Green tea and its catechins inhibit breast cancer xenografts. Nutr. Cancer 2001, 40, 149-156.
37. Thangapazham, R. J.; Singh, A. K.; Sharma, A.; Warren, J.; Gaddipati, J. P.; Maheshwari, R. K. Green tea polyphenols and its constituents epigallocatechin gallate inhibits proliferation of human cancer cells in vitro and in vivo. Cancer Lett. 2006, in press.
38. Green, J. E.; Shibata, M. A.; Shibata, E.; Moon, R. C.; Anver, M. R.; Kelloff, G.; Lubet, R. 2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Cancer Res. 2001, 61, 7449-7455.
39. Hou, Z.; Lambert, J. D.; Chin, K. V.; Yang, C. S. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat. Res. 2004, 555, 3-19.
40. Yoshino, K.; Hara, Y.; Sano, M.; Tomita, S. Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol. Pharm. Bull. 1994, 17, 146-149.
41. Roy, A. M.; Baliga, M. S.; Katiyar, S. K. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3-activation. Mol. Cancer Ther. 2005, 4, 81-90.
42. Baliga, M. S.; Meleth, S.; Katiyar, S. S. Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in in vitro and in vivo systems. Clin. Cancer Res. 2005, 11, 1918-1927.
43. Freireich, E. J.; Gehan, E. A.; Rall, D. P.; Schmidt, L. H.; Skipper, H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 1966, 50, 219-244.